Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Mauna Kea Technologies's Net Margin % or its related term are showing as below:
STU:1MK'
s Net Margin % Range Over the Past 10 Years
Min: -205.52 Med: -151.35 Max: 131
Current: 131
STU:1MK's Net Margin % is ranked better than 99.39% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs STU:1MK: 131.00
Mauna Kea Technologies (STU:1MK) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mauna Kea Technologies Net Margin % Related Terms
Mauna Kea Technologies Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Mauna Kea Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mauna Kea Technologies Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Net Margin % distribution charts can be found below:
* The bar in red indicates where Mauna Kea Technologies's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mauna Kea Technologies (STU:1MK) has a Net Margin % of 340.73% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Mauna Kea Technologies and its competitors. According to the industry distribution chart, Mauna Kea Technologies ranks #5 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 0.59999999999999%.
Is Mauna Kea Technologies' Net Margin % too high?
Mauna Kea Technologies' current Net Margin % is 340.73%. The Medical Devices & Instruments industry median Net Margin % is 2.05. Mauna Kea Technologies' value of 340.73% is 16521% above this industry median. Based on the distribution chart, Mauna Kea Technologies ranks #5 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mauna Kea Technologies has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mauna Kea Technologies' Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mauna Kea Technologies ranks #5 out of 817 companies for Net Margin %. This places Mauna Kea Technologies in the top 1% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.05. Mauna Kea Technologies' value of 340.73% is 16521% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mauna Kea Technologies's current Net Margin % of 340.73% is 16521% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Mauna Kea Technologies and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mauna Kea Technologies's current Net Margin % is 340.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mauna Kea Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mauna Kea Technologies (STU:1MK) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.11, compared to a current price of €0.15 — trading 39.1% above its estimated fair value. The current Net Margin % is 340.73% and 16521% above the Medical Devices & Instruments industry median of 2.05. Mauna Kea Technologies' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Mauna Kea Technologies (STU:1MK), the current Net Margin % is 340.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mauna Kea Technologies (STU:1MK) Overvalued in 2026?
Based on GuruFocus' analysis, Mauna Kea Technologies stock appears to be overvalued.
The current stock price of €0.15 is trading 39.1% above its estimated GF Value™ of €0.11.
GuruFocus considers Mauna Kea Technologies to be Significantly Overvalued.
Key valuation signals for STU:1MK:
Net Margin %: 340.73%
GF Value™: €0.11 vs. price of €0.15 (39.1% above fair value)
Industry Position: 16521% above the Medical Devices & Instruments median (#5 of 817)
No single metric tells the full story. See the STU:1MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.
47GF Score
Get the complete analysis for STU:1MK
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1MK has been successfully added to your 
